Home | Add Company | Subscribe | Search | Contact





Add Company

Your company can benefit from enhanced listings. Questions? Read our FAQ first.


Personalized notification service and newsletter info

Subscribe (free) to get notified of new additions.


Learn more About us and about our Services


Contact us

Ranitidinum hydrochloridum

75-150-300 mg Tablets. Readily available Recent EU registration dossier

Offer available for: licensing

Pharmaceutical form and dosage: 75-150-300 mg Tablets


- Generics
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)

Therapeutic target:

- Gastrointestinal

Action: Ant-ulcerants - H2 antagonists (Gastro)

Company Contact

Corporate data: PharmaRegistrations

Contact for this offer: Lieve Vermassen

Or check this company's:

Full Description:
Ranitidinum hydrochloridum 75-150-300 mg Tablets dossier:
-New readily available for licensing
-Marketing Authorization obtained in The Netherlands and to be obtained soon Belgium (we can also register in other countries)
-Stability: 25C: 36 months, 40C: 6 months

Availability and Market information:

Status: Registered (MA obtained)

Market(s) and Registration Info: (date: concerns Marketing Authorization)
- Netherlands : 2000
- Belgium : 2001
Registration info: Obtained in The Netherlands, on-going in Belgium
On request: registration in other countries

Market information

Other Market Info:

Patent Information:
Name: Zantac
Patent info: Expired

Suggestion box | Disclaimer | Privacy Policy | Rules & Regulations
Copyright© Cofidei, Inc. Last modified: 31-Oct-2001.

Home | Add Company | Subscribe to Newsletter | Search Companies | Search Offers | Power search